JP2022525549A5 - - Google Patents
Info
- Publication number
- JP2022525549A5 JP2022525549A5 JP2021556556A JP2021556556A JP2022525549A5 JP 2022525549 A5 JP2022525549 A5 JP 2022525549A5 JP 2021556556 A JP2021556556 A JP 2021556556A JP 2021556556 A JP2021556556 A JP 2021556556A JP 2022525549 A5 JP2022525549 A5 JP 2022525549A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- mtor inhibitor
- individual
- albumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025060500A JP2025118604A (ja) | 2019-03-19 | 2025-04-01 | 疾患の治療のための、ｍＴＯＲ阻害剤およびアルブミンを含むナノ粒子の皮下投与 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962820842P | 2019-03-19 | 2019-03-19 | |
| US201962820838P | 2019-03-19 | 2019-03-19 | |
| US62/820,838 | 2019-03-19 | ||
| US62/820,842 | 2019-03-19 | ||
| PCT/US2020/023366 WO2020191053A1 (en) | 2019-03-19 | 2020-03-18 | Subcutaneous administration of nanoparticles comprising an mtor inhibitor and albumin for treatment of diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060500A Division JP2025118604A (ja) | 2019-03-19 | 2025-04-01 | 疾患の治療のための、ｍＴＯＲ阻害剤およびアルブミンを含むナノ粒子の皮下投与 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525549A JP2022525549A (ja) | 2022-05-17 |
| JP2022525549A5 true JP2022525549A5 (https=) | 2023-03-28 |
Family
ID=72519161
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556556A Pending JP2022525549A (ja) | 2019-03-19 | 2020-03-18 | 疾患の治療のための、ｍＴＯＲ阻害剤およびアルブミンを含むナノ粒子の皮下投与 |
| JP2025060500A Pending JP2025118604A (ja) | 2019-03-19 | 2025-04-01 | 疾患の治療のための、ｍＴＯＲ阻害剤およびアルブミンを含むナノ粒子の皮下投与 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025060500A Pending JP2025118604A (ja) | 2019-03-19 | 2025-04-01 | 疾患の治療のための、ｍＴＯＲ阻害剤およびアルブミンを含むナノ粒子の皮下投与 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220054404A1 (https=) |
| EP (1) | EP3941551A4 (https=) |
| JP (2) | JP2022525549A (https=) |
| KR (1) | KR102936433B1 (https=) |
| CN (2) | CN113795287A (https=) |
| AU (1) | AU2020241730B2 (https=) |
| CA (1) | CA3133988A1 (https=) |
| MX (1) | MX2021011230A (https=) |
| WO (1) | WO2020191053A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES3009356T3 (en) | 2015-06-29 | 2025-03-26 | Abraxis Bioscience Llc | Nanoparticles comprising sirolimus and an albumin for use in treating epithelioid cell tumors |
| IL277402B1 (en) | 2018-03-20 | 2026-04-01 | Abraxis Bioscience Llc | Methods for treating central nervous system disorders using administration of MTOR inhibitor nanoparticles and albumin |
| KR102936433B1 (ko) | 2019-03-19 | 2026-03-09 | 아브락시스 바이오사이언스, 엘엘씨 | 질환의 치료를 위한 mTOR 억제제 및 알부민을 포함하는 나노입자의 피하 투여 |
| BR112022007710A2 (pt) | 2019-10-28 | 2022-07-12 | Abraxis Bioscience Llc | Composições farmacêuticas de albumina e rapamicina |
| TW202123935A (zh) * | 2019-11-11 | 2021-07-01 | 美商亞伯辛生物科學有限責任公司 | 用於奈米粒子組合物之生物標記 |
| CN120187414A (zh) * | 2022-11-25 | 2025-06-20 | 克利凯生物公司 | 用于靶向炎症性巨噬细胞的纳米平台以及包含其的用于预防或治疗炎症性疾病的组合物 |
| KR20250081554A (ko) * | 2023-11-29 | 2025-06-05 | 주식회사 에스엔바이오사이언스 | 시롤리무스 및 알부민을 포함하는 나노입자, 이를 포함하는 피하투여용 약제학적 조성물 및 이의 제조방법 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1684730A (zh) * | 2002-09-04 | 2005-10-19 | 梅里迪安医学技术公司 | 药品输送装置 |
| CN101730526A (zh) * | 2007-03-07 | 2010-06-09 | 阿布拉科斯生物科学有限公司 | 作为抗癌剂的包含雷帕霉素和白蛋白的纳米颗粒 |
| EP2131821B1 (en) * | 2007-03-07 | 2018-05-09 | Abraxis BioScience, LLC | Nanoparticle comprising rapamycin and albumin as anticancer agent |
| US20100166869A1 (en) * | 2007-05-03 | 2010-07-01 | Desai Neil P | Methods and compositions for treating pulmonary hypertension |
| US10143700B2 (en) * | 2013-02-19 | 2018-12-04 | Amrita Vishwa Vidyapeetham | Nanoparticle formulations for delivering multiple therapeutic agents |
| RU2015143490A (ru) * | 2013-03-14 | 2017-04-26 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения рака мочевого пузыря |
| CN106573111B (zh) * | 2014-08-18 | 2020-03-31 | 温德加普医疗股份有限公司 | 便携式药物混合和递送装置及相关方法 |
| RU2732908C2 (ru) * | 2014-10-07 | 2020-09-24 | ЭйАй ТЕРАПЬЮТИКС, ИНК. | Ингаляционная лекарственная форма рапамицина для лечения легочной гипертензии |
| JP2018521058A (ja) * | 2015-06-29 | 2018-08-02 | アブラクシス バイオサイエンス， エルエルシー | ナノ粒子ｍＴＯＲ阻害剤併用治療を使用して固形腫瘍を処置する方法 |
| ES3009356T3 (en) * | 2015-06-29 | 2025-03-26 | Abraxis Bioscience Llc | Nanoparticles comprising sirolimus and an albumin for use in treating epithelioid cell tumors |
| KR20240144442A (ko) * | 2015-06-29 | 2024-10-02 | 아브락시스 바이오사이언스, 엘엘씨 | 나노입자 조성물에 대한 바이오마커 |
| CN107921050A (zh) * | 2015-06-29 | 2018-04-17 | 阿布拉科斯生物科学有限公司 | 使用纳米颗粒mtor抑制剂联合疗法治疗血液学恶性肿瘤的方法 |
| EP3440113A1 (en) * | 2016-04-08 | 2019-02-13 | Gilead Sciences, Inc. | Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases |
| EP3518923A4 (en) | 2016-09-28 | 2020-06-17 | Abraxis BioScience, LLC | METHOD FOR TREATING MITOCHONDRIAL AND METABOLIC DISORDERS |
| WO2018153984A1 (en) * | 2017-02-23 | 2018-08-30 | Universität Bern | Mtor inhibitor-corticoid combination therapy for multiple sclerosis |
| TW201840319A (zh) * | 2017-02-24 | 2018-11-16 | 德商拜耳廠股份有限公司 | Atr激酶抑制劑與鐳-223鹽之組合 |
| TW202015659A (zh) * | 2018-05-22 | 2020-05-01 | 美商亞伯辛生物科學有限責任公司 | 用於治療肺高血壓之方法及組合物 |
| KR102936433B1 (ko) | 2019-03-19 | 2026-03-09 | 아브락시스 바이오사이언스, 엘엘씨 | 질환의 치료를 위한 mTOR 억제제 및 알부민을 포함하는 나노입자의 피하 투여 |
-
2020
- 2020-03-18 KR KR1020217033109A patent/KR102936433B1/ko active Active
- 2020-03-18 CN CN202080034543.9A patent/CN113795287A/zh active Pending
- 2020-03-18 AU AU2020241730A patent/AU2020241730B2/en active Active
- 2020-03-18 MX MX2021011230A patent/MX2021011230A/es unknown
- 2020-03-18 CN CN202510438859.9A patent/CN120267635A/zh active Pending
- 2020-03-18 EP EP20774418.6A patent/EP3941551A4/en active Pending
- 2020-03-18 WO PCT/US2020/023366 patent/WO2020191053A1/en not_active Ceased
- 2020-03-18 JP JP2021556556A patent/JP2022525549A/ja active Pending
- 2020-03-18 CA CA3133988A patent/CA3133988A1/en active Pending
- 2020-03-18 US US17/438,825 patent/US20220054404A1/en active Pending
-
2025
- 2025-04-01 JP JP2025060500A patent/JP2025118604A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022525549A5 (https=) | ||
| Mohammadi et al. | Bacterial cellulose-based composites as vehicles for dermal and transdermal drug delivery: a review | |
| JP2005506367A5 (https=) | ||
| SK137996A3 (en) | Cancer treatment and metastasis prevention | |
| JP2006514092A5 (https=) | ||
| JP2024517085A5 (https=) | ||
| CN107137417B (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| CN100490820C (zh) | 单独包含去纤苷酸或与其它抗肿瘤剂联合的抗肿瘤制剂 | |
| JP2019503335A (ja) | ジメチルアミノミケリオリドの使用 | |
| RU2063770C1 (ru) | Способ лечения гнойно-воспалительных заболеваний легких | |
| CN104758304B (zh) | 三七皂苷r1的医药用途 | |
| CN118526500A (zh) | 利匹韦林的医药新用途 | |
| Karatieieva et al. | Treatment of pyoinflammatory complications with individually selected ozone dose in patients with diabetes | |
| RU2122844C1 (ru) | Способ лечения герпетического кератита с изъязвлением | |
| RU2200557C1 (ru) | Способ лечения гипертрофических и келоидных рубцов | |
| JP2023504205A5 (https=) | ||
| JPH027293B2 (https=) | ||
| HK1205951A1 (en) | Use of 7-t-butoxyiminomethylcamptothecin for the prepartion of a medicament for the treatment of uterine neoplasms | |
| RU2586043C1 (ru) | Способ профилактики и лечения осложнений при лучевой терапии рака кожи | |
| JP2004503472A (ja) | ボーラスまたは間欠的な静脈内注入による、抗内毒素薬の投与 | |
| RU2066186C1 (ru) | Средство для купирования приступов удушья при бронхиальной астме | |
| CN102091062A (zh) | 一种采取吸入给药紫杉醇治疗肺癌的方法 | |
| JP2609882B2 (ja) | 脱髄性疾患治療薬 | |
| JP2003519185A (ja) | エノキサパリンの新規治療的使用 | |
| RU2103008C1 (ru) | Способ стимуляции apud-системы |